Pablo Cagnoni - CEO and President, Rubius Therapeutics, Inc

As of February 2, 2021


Pablo Cagnoni Net Worth

  • Net worth is estimated to be at least $2.01M
  • Owns at least 21,000 units of Rubius Therapeutics, Inc stock

Pablo Cagnoni Trading

  • Largest purchase of shares was 21,000 units , worth over $98.69K on April 15, 2020
  • In total has made about 5 transactions over 3 years
  • Usually trades in February, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Pablo Cagnoni Mailing Address

  • Mailing address is Onyx Pharmaceuticals, Inc. 249 E. Grand Ave. South San Francisco CA 94080 CA

Rubius Therapeutics, Inc Insider Trading

  • The most recent transaction was 210,000 units bought on March 23, 2021 by Flagship Ventures Fund Iv General Partner Llc, Flagship Ventures Fund Iv Lp, Flagship Ventures Fund V General Partner Llc, Flagship Ventures Fund V Lp, Flagship Ventures Opportunities Fund I General Partner Llc, Flagship Ventures Opportunities Fund I Lp and Noubar Afeyan worth over $6.09M
  • In the last 3 years, insiders at Rubius Therapeutics, Inc sold an estimated value of $5.65M and bought an estimated value of $8.13M
  • The most active traders are David Epstein, Director,  Christopher Carpenter, Chief Medical Officer,  and Noubar Afeyan, Director
  • Insider trading is most common in May, with the busiest year in 2019

Rubius Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1